ZVRA 股價走勢圖
ZVRA 股票價格預測
Zevra Therapeutics Inc
$10.53
0.09%
$0
收盤價：Aug 05, 16:00:00 GMT-4
$10.58
0.47%
$0.05
盤後：Aug 05, 18:44:21 GMT-4
返回
Zevra Therapeutics Inc (ZVRA) 股票價格預測
關鍵數據
前收市價
$10.52
開盤價
$10.59
當日範圍
$10.38 - $10.66
52週區間
$7.16 - $15.03
交易量
761.9K
平均成交量
1.5M
股息收益率
--
每股盈餘 (TTM)
2.15
市值
$625.4M
什麼是 ZVRA？
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The company is headquartered in Celebration, Florida and currently employs 61 full-time employees. The company went IPO on 2015-04-16. The company has a diverse portfolio of products and product candidates, which includes pre-clinical, clinical, and commercial stage assets. Its active commercial products and development assets include MIPLYFFA, OLPRUVA, Celiprolol, KP1077IH, KP1077N and AZSTARYS. MIPLYFFA (arimoclomol) is its approved therapy for the treatment of Niemann-Pick disease type C (NPC). OLPRUVA (sodium phenylbutyrate) is its treatment for the treatment of certain urea cycle disorders (UCDs). Celiprolol is its investigational clinical candidate for the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). KP1077 is its product candidate intended for the treatment of rare sleep disorders. KP1077N is a clinical development candidate for narcolepsy. AZSTARYS is for the treatment of attention deficit and hyperactivity disorder.
